Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00356668 · ClinicalTrials.gov registry record · Phase 3
Humidified High Flow Nasal Cannula as Compared to Nasal Continuous Positive Airway Pressure
A Phase 3 study, sponsored by Children's Hospitals and Clinics of Minnesota.
- Completed
- Registry status
- Phase 3
- Development phase
- 16
- Enrollment target
NCT00356668: Completed Phase 3 study, sponsored by Children's Hospitals and Clinics of Minnesota.
NCT00356668 is a Phase 3 study that has completed, run by Children's Hospitals and Clinics of Minnesota. The registered enrollment target is 16 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00356668, a Phase 3 study, has completed, sponsored by Children's Hospitals and Clinics of Minnesota.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 16 participants
- Enrollment target
Study Summary
The specific aims of this study are to evaluate the amount of high flow nasal cannula (HFNC) gas flow required to generate an equivalent positive distending pressure as that provided by nasal continuous positive airway pressure (NCPAP) of 6 cm H2O, assess the relationships between positive distending pressure, gas flow, oxygen requirement, and patient weight, and lastly, develop an appropriate protocol to be used in the NICU for transitioning patients from NCPAP to an equivalent amount of HFNC.
Interventions
- DEVICE High Flow Nasal Cannula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2006-07 |
| Est. Completion | 2007-09 |
| Phase | Phase 3 |
What the finished NCT00356668 record still lists
NCT00356668 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which High Flow Nasal Cannula is the first listed.
NCT00356668 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00356668 about?
NCT00356668 is a clinical study titled "Humidified High Flow Nasal Cannula as Compared to Nasal Continuous Positive Airway Pressure". The specific aims of this study are to evaluate the amount of high flow nasal cannula (HFNC) gas flow required to generate an equivalent positive distending pressure as that provided by nasal continuous positive airway pressure (NCPAP) of 6 cm H2O, assess the relationships between positive distendin...
What is the current status of trial NCT00356668?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 16 participants. The study started on 2006-07. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00356668?
The interventions under investigation include: High Flow Nasal Cannula (DEVICE).
Who is sponsoring clinical trial NCT00356668?
This trial is sponsored by Children's Hospitals and Clinics of Minnesota, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00356668's enrollment target sits among peer trials
16 1974th of 2000 higher than 24 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia